Gastrointestinal manifestations of COVID-19 in pediatric age
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27755Keywords:
abdominal pain, COVID-19, diarrhea, gastrointestinal symptoms, nausea, pediatric age, vomitingAbstract
Introduction: Gastrointestinal (GI) symptoms associated with COVID-19 have become increasingly relevant, particularly in pediatric age. The expression of angiotensin II receptors in the GI tract may explain, not only the predominance of GI symptoms, but also the presence of isolated GI manifestations of the disease in some cases. The aim of this study was to characterize a population of pediatric patients with COVID-19 and investigate the association of this disease presentation with GI involvement and disease severity.
Methods: Retrospective, observational study of pediatric patients with positive SARS-CoV-2 polymerase chain reaction (PCR) testing between March 2020 and September 2021. Data was retrieved from patients’ clinical records.
Results: A total of 241 patients were included, 132 (54.7%) of whom male, with a median age of 48 months (interquartile range [IQR] 10-144 months). The disease had multiple presentations, including at least one GI complaint in 39.4% of patients and exclusive GI symptoms in 3.3%. GI involvement significantly correlated with patients’ age, being more frequent in younger children (p=0.001), and with fever (p=0.001). In the group with GI involvement, 86 patients (90.5%) had mild, 7 (7.4%) moderate, and 2 (2.1%) severe disease.
Conclusion: COVID-19 GI manifestations occur more frequently in pediatric patients (39.4% in the present study) than in adult counterparts (12% according to the literature). Telephone follow-up made it possible to detect symptoms that could otherwise go unnoticed. Given the wide variety of clinical symptoms, clinicians should keep a high index of suspicion for this infection in young infants presenting with GI symptoms, even in absence of fever.
Downloads
References
Ma C, Cong Y, Zhang H. COVID-19 and the Digestive System. Am J Gastroenterol. 2020;115(7):1003-1006. doi: https://doi.org/10.14309/ajg.0000000000000691.
Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518-1519. doi: https://doi.org/10.1053/j.gastro.2020.02.054.
Zhang W, Du RH, Li B, Zheng X-S, Yang X-L, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg. Microbes. Infect. 2020;9(1):386-389. doi: https://doi.org/10.1080/22221751.2020.1729071.
Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502-505. doi: https://doi.org/10.1038/s41591-020-0817-4.
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020;382(10):929-936. doi: https://doi.org/10.1056/NEJMoa2001191.
Tang A, Tong Z, Wang H, Dai Y, Li K, Liu J, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337-1339. doi: https://doi.org/10.3201/eid2606.200301.
Young BE, Ong SWX, Kalimuddin S, Low, JG, Tan SY, Loh J, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488-1494. doi: https://doi.org/10.1001/jama.2020.3204.
Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831-1833.e3. doi: https://doi.org/10.1053/j.gastro.2020.02.055.
Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1-2):107-110. doi: https://doi.org/10.1016/s0014-5793(02)03640-2.
Xiong XL, Wong KK, Chi SQ, Zhou A, Tang J, Zhou L, et al. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms. Gut. 2021;70(2):436-438. doi: https://doi.org/10.1136/gutjnl-2020-321486.
Robinson J, Banerjee I, Leclézio A. (2021). Gastrointestinal manifestations as early symptoms to diagnose COVID-19 paediatric cases. Journal of Biomedical Sciences. 2021;8(1), 5–7. https://doi.org/10.3126/jbs.v8i1.38452.
Akobeng AK, Grafton-Clarke C, Abdelgadir I, Twum-Barimah E, Gordon M. Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis. Frontline Gastroenterol. 2020;12(4):332-337. doi: https://doi.org/10.1136/flgastro-2020-101529.
Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, et al. Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review. World J Gastroenterol. 2021;27(23):3303-3316. doi: https://doi.org/10.3748/wjg.v27.i23.3303.
Wang JG, Cui HR, Tang HB, Deng XL. Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis. Sci Rep. 2020;10(1):17846. Published 2020 Oct 20. doi: https://doi.org/10.1038/s41598-020-74913-0.
Matthai J, Shanmugam N, Sobhan P; Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition; Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children. Indian Pediatr. 2020;57(6):533-535. doi: https://doi.org/10.1007/s13312-020-1851-5.
Chiappini E, Licari A, Motisi MA, Manti S, Marseglia GL, Galli L, et al. Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician. Pediatr Allergy Immunol. 2020;31 Suppl 26(Suppl 26):92-95. doi: https://doi.org/10.1111/pai.13373.
Obesity and overweight. (s.d.). World Health Organization(WHO). https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
Oba J, Carvalho WB, Silva CA, Delgado AF. Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians. Einstein (Sao Paulo). 2020;18:eRW5774. doi: https://doi.org/10.31744/einstein_journal/2020rw5774.
Mania A, Pokorska-Śpiewak M, Figlerowicz M, Pawłowska M, Mazur-Melewska K, Faltin K, et al. Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19-analysis of a paediatric part of Polish register SARSTer. Infect Dis (Lond). 2022;54(3):196-204. doi: https://doi.org/10.1080/23744235.2021.1995628.
Mehta NS, Mytton OT, Mullins EWS, Fowler TA, Falconer CL, Murphy OB, et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clin Infect Dis. 2020;71(9):2469-2479. doi: https://doi.org/10.1093/cid/ciaa556.
Badal S, Thapa Bajgain K, Badal S, Thapa R, Bajgain BB, Santana MJ. Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis. J Clin Virol. 2021;135:104715. doi: https://doi.org/10.1016/j.jcv.2020.104715.
Bolia R, Ranjan R, Bhat NK. Recognising the Gastrointestinal Manifestation of Pediatric Coronavirus Disease 2019. Indian J Pediatr. 2021;88(1):101-102. doi: https://doi.org/10.1007/s12098-020-03481-y.
Wang J, Zhu L, Liu L, Zhao X, Zhang Z, Xue L, et al. Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19. Obesity (Silver Spring). 2020;28(11):2049-2055. doi: https://doi.org/10.1002/oby.22979.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Joana Queirós, Luís Salazar, Dora Sousa, Sara Mosca, Alexandre Fernandes, Carla Teixeira, Marta Tavares, Laura Marques, Rosa Lima
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.
